ChemicalBook >> CAS DataBase List >>Ponatinib-d8
Ponatinib-d8
- CAS No.
- 1562993-37-6
- Chemical Name:
- Ponatinib-d8
- Synonyms
- AP24534 D8;Ponatinib-d8;[2H8]-Ponatinib;Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)methyl]-3-(trifluoromethyl)phenyl]-
- CBNumber:
- CB32675379
- Molecular Formula:
- C29H27F3N6O
- Molecular Weight:
- 532.57
- MDL Number:
- MFCD22380805
- MOL File:
- 1562993-37-6.mol
Last updated:2024-10-28 16:48:35
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302+H312+H332-H315-H319 | |||||||||
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P501 | |||||||||
| NFPA 704 |
|
Ponatinib-d8 price More Price(3)
Ponatinib-d8 Chemical Properties,Uses,Production
Uses
Ponatinib-d8 is an isotope labelled compound of Ponatinib (P688250). Ponatinib is a tyrosine kinase inhibitors (TKI) and used to treat chronic myeloid leukemia (CML) (1,2,3). Ponatinib is also used in combination with other drugs, such as forskolin, to combat TKI resistance in patient with CML (3), targeted drug in small-cell lung cancer. It is a COVID19-related research product.
Ponatinib-d8 Preparation Products And Raw materials
Raw materials
Preparation Products
Ponatinib-d8 Suppliers
Global( 22)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32161 | 58 |
| TargetMol Chemicals Inc. | support@targetmol.com | United States | 38631 | 58 | |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
| Artis Biotech Co. Ltd. | 0575-18780151478 18582380095 | sales@artisbio.com | China | 2966 | 58 |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9806 | 58 |
| Chengdu Novel Biomedical Co., Ltd. | 028-85255396 18302801538 | cdnovell@163.com | China | 2314 | 58 |
| Shanghai Hongye Biotechnology Co. Ltd | 400-9205774 | sales@glpbio.cn | China | 6777 | 58 |
| Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 +86-13028896684; | sales@rrkchem.com | China | 57423 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11218 | 58 |
| Manhag Testing Technology Co., Ltd | 020-020-3846236 17688849268 | 2443244976@qq.com | China | 7775 | 58 |
View Lastest Price from Ponatinib-d8 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-10-28 | Ponatinib-d8
1562993-37-6
|
US $678.00-278.00 / mg | 10g | TargetMol Chemicals Inc. |
-
- Ponatinib-d8
1562993-37-6
- US $678.00-278.00 / mg
- TargetMol Chemicals Inc.
Ponatinib-d8
[2H8]-Ponatinib
AP24534 D8
Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)methyl]-3-(trifluoromethyl)phenyl]-
1562993-37-6